Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
17 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-17/deciphera-receives-european-commission-approval-of-romvimza-vimseltinib-for-the-treatment-of-teno
28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250725009938/en/Deciphera-Announces-Positive-CHMP-Opinion-for-ROMVIMZA-vimseltinib-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT
20 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/20/3102647/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-QINLOCK-ripretinib.html
15 Feb 2025
// FDA
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vimseltinib-symptomatic-tenosynovial-giant-cell-tumor
12 Jun 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-06-12/ono-acquires-deciphera-pharmaceuticals/
03 Jun 2024
// BUSINESSWIRE
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE